Literature DB >> 70220

Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies.

M Chien, A P Grollman, S B Horwitz.   

Abstract

The interaction of bleomycin A2 with DNA has been examined by fluorescence spectroscopy and proton magnetic resonance techniques. Fluorescence bands observed at 353 and 405 nm in the spectrum of bleomycin were assigned to the bithiazole and 4-aminopyrimidine rings, respectively. Quenching of bithiazole fluorescence by DNA was used to determine apparent equilibrium constants for the complex which, in 2.5 mM tris(hydroxymethyl)aminomethane buffer, pH 8.4, are 1.2 X 10(5) M-1 for bleomycin and 1.4 X 10(5) M-1 for tripeptide S, a partial acid hydrolysis product of the antibiotic. Uner these conditions, one molecule of bleomycin binds for every five to six base pairs in DNA. In the proton magnetic resonance spectrum of bleomycin, resonances emanating from the bithiazole rings and dimethylsulfonium groups are preferentially broadened and reduced in intensity in the presence of DNA, suggesting that these moieties bind most tightly to the polymer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70220     DOI: 10.1021/bi00635a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Studying the effect of a charged surface on the interaction of bleomycin with DNA using an atomic force microscope.

Authors:  Olivier Piétrement; David Pastré; Fabrice Landousy; Marie-Odile David; Stéphane Fusil; Loïc Hamon; Alain Zozime; Eric Le Cam
Journal:  Eur Biophys J       Date:  2004-11-05       Impact factor: 1.733

2.  Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin.

Authors:  Najme Sadat Hosseini Motlagh; Parviz Parvin; Fatemah Ghasemi; Fatemeh Atyabi
Journal:  Biomed Opt Express       Date:  2016-05-25       Impact factor: 3.732

3.  Interaction of a new fluorescent probe with DNA and its use in determination of DNA.

Authors:  Fang-Ying Wu; Fei-Yan Xie; Yu-Mei Wu; Jong-In Hong
Journal:  J Fluoresc       Date:  2007-10-24       Impact factor: 2.217

4.  A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.

Authors:  E Ginsburg; T E Gram; M A Trush
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Chemical properties and tumor affinity of separated isomers of cobalt-bleomycin.

Authors:  J Kakinuma; R Kagiyama; H Orii
Journal:  Eur J Nucl Med       Date:  1980-04

6.  Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.

Authors:  T Yamauchi; T A Raffin; P Yang; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering.

Authors:  P Dumas; M Bergdoll; C Cagnon; J M Masson
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

Review 8.  Contributions of NMR to the understanding of the coordination chemistry and DNA interactions of metallo-bleomycins.

Authors:  Teresa Lehmann; Elena Topchiy
Journal:  Molecules       Date:  2013-08-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.